African-American and older patients with advanced lung cancer can be effectively treated with a new, federally approved therapy, according to researchers from the University of Cincinnati. Such patients are not good candidates for chemotherapy.
The findings were published in the journal Libertas Academica.
The treatment the researchers focused on is gefitinib, a drug that’s already used to treat other kinds of cancer. The study looked at the effect of the drug on patients with non-small cell lung cancer, which does not have many treatment options.